Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Mindful Walking Neural Correlates of Executive Function in SC Older Adults at Risk of Dementias

5 de junho de 2026 atualizado por: Chih-Hsiang Yang, University of South Carolina

The Impact of Mindful Walking on Neural Correlates of Executive Function in SC Older Adults at Risk of Alzheimer's and Dementias

Mindful walking is a promising and practical strategy because it combines two activities known to support healthy aging: walking and mindfulness. Unlike many structured exercise programs, mindful walking is low intensity, accessible, and easier to sustain in daily life. It may be especially useful for older adults at elevated risk for ADRD. However, most existing mindful walking studies have focused on mental health outcomes, such as stress reduction, rather than cognitive health. Little is known about whether mindful walking can support cognition or how it may influence brain function. To address this gap and strengthen a future R01 resubmission, the investigators propose a two-arm randomized controlled pilot trial using functional near-infrared spectroscopy (fNIRS), a safe, non-invasive brain imaging method. fNIRS measures brain activity through sensors placed on the scalp and is well-suited for repeated assessments in older adults because it is quiet, portable, painless, and cost-effective. The investigators will recruit racially and ethnically diverse middle-aged and older adults from the Midlands of South Carolina who are at elevated risk for ADRD. Participants will be randomly assigned to one of two groups: mindful walking or walking-only control. Both groups will complete 8 staff-supervised individual sessions over 4 weeks. The mindful walking group will learn and practice simple mindfulness skills while walking in multiple settings, including lab-based, indoor, and outdoor environments, to support real-world use. Findings from this pilot study will provide important evidence on whether mindful walking can support brain and cognitive health in adults at elevated risk for ADRD. The results will also help establish a practical, scalable, and sustainable prevention strategy for underserved aging populations in South Carolina.

Visão geral do estudo

Status

Recrutamento

Descrição detalhada

The number of older adults living with Alzheimer's disease and related dementias (ADRD) is escalating around the world, yet no effective treatment is currently available. Non-pharmacological early preventive strategies are urgently needed to mitigate the social and economic burden of ADRD and to sustain quality of life in the aging population, including the seniors living in South Carolina (SC). Mindful walking represents a promising prevention approach to sustain cognition, as it simultaneously practices mindfulness skills during physical activity (walking). However, existing mindful walking programs primarily focused on mental health outcomes (e.g., stress reduction) and overlooked the potential efficacy on cognition. This lower-intensity lifestyle physical activity may be a more viable and inclusive prevention strategy with greater scalability and long-term sustainability to serve ADRD at-risk aging populations. Our preliminary work in African American older adults around the Midlands of SC has established preliminary signals that mindful walking is feasible, acceptable, and it may sustain proximal cognitive function. However, the literature to date has not tested the neural-level correlates underlying mindful walking to infer the potential mechanism related to executive function enhancement. This is also a gap raised by a reviewer from our scored R01 in 2023 (not funded, 40th percentile). To address this knowledge gap and strengthen our R01 resubmission, our team proposes to conduct a two-arm randomized controlled pilot trial to determine the neural-level underpinning of mindful walking using the Functional near-infrared spectroscopy (fNIRS). fNIRS offers a non-invasive neuroimaging tool that uses source-detector channels placed on the scalp to measure event-evoked neural activities across the lifespan (e.g., engaged executive function while practicing mindfulness skills). fNIRS is a device that is well-suited for within-subjects repeated data collection in older adults because it is noiseless and compact, painless, and cost-effective, making it suitable to apply in a behavioral trial that requires multiple assessments. This randomized controlled trial will recruit race and ethnically diverse middle-aged and older adults who have elevated risk(s) for ADRD from the Midlands of SC. Participants will be randomly assigned to participate in 8 sessions of individual mindful walking or a walking-only control group supervised by the staff across 4 weeks. The mindful walking group will be instructed to practice simple but fundamental mindfulness skills in multiple settings to facilitate real-world skill translation (in lab, indoor, outdoor). This study will administer lab-based measures of cognitive assessments, including the fNIRS, MoCA, and NIH Toolbox Cognition Battery, to examine group differences in neural activations measured using fNIRS (Aim 1) and the concordance between executive function measured using fNIRS, MoCA, and NIH Toolbox (Aim 2). Findings from this study have the potential to provide a viable and achievable behavioral strategy that can be engaged in daily life to address cognitive health and reduce ADRD risk among underserved older populations in the Midlands of SC. It will also well-position our team to submit R01s in the following years to support this timely and critical research.

Tipo de estudo

Intervencional

Inscrição (Estimado)

54

Estágio

  • Fase 2

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

    • South Carolina
      • Columbia, South Carolina, Estados Unidos, 29201
        • Recrutamento
        • University of South Carolina
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Sim

Descrição

Inclusion Criteria:

  1. Age 60 or older
  2. Sedentary (sit ≥9hrs per day) and not meeting the US physical activity guidelines
  3. Have at least one of the following ADRD risk factors:

    i. family history of ADRD (>= first-degree relative) ii. subjective experience of cognitive complaints iii. currently overweight or obese (BMI≥25)

  4. Adequate hearing, visual and cognitive ability to complete study tasks and assessments
  5. Able to walk without others' assistance
  6. Medically stable with or without medication (do not expect to have major health status changes or a surgery in the next 4 months)

Exclusion Criteria:

  1. Diagnosis of ADRD or other brain abnormalities (i.e., strokes, epilepsy, Parkinson's disease)
  2. Diagnosis of mental disorders (i.e., depression)
  3. Inability to complete surveys on mobile device or wear the activity monitor (i.e., due to arthritis, physical limitations, or other reasons)
  4. Plan to move or have surgery in next 4 months
  5. Currently participate in other study involving physical activity or cognitive training that may interfere with the study outcomes
  6. Unable to provide consent due to disabilities

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Prevenção
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Mindful walking arm
Older adults will participate in 8 sessions of mindful walking over one month
Implementing mindfulness skills during the walking movement
Comparador Ativo: Walking-only arm
Older adults will participate in 8 sessions of walking over one month
Implementing mindfulness skills during the walking movement

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Hemodynamic activation signal
Prazo: Assessed at baseline, 4 weeks, 8 weeks
Hemodynamic activation in the prefrontal and parietal regions as an indication of EF. Neural activation will be measured using functional nearinfrared spectroscopy (fNIRS).
Assessed at baseline, 4 weeks, 8 weeks

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Neuropsychological function
Prazo: Assessed at baseline, 4 weeks, 8 weeks
Montreal Cognitive Assessment (MoCA) is sensitive to measure normal cognitive aging from those with mild cognitive decline. MoCA scores range from 1-30 to detect cognitive impairment. Higher scores indicate better cognitive function.
Assessed at baseline, 4 weeks, 8 weeks
Executive function
Prazo: Assessed at Baseline, 4 weeks, 8 weeks
NIH Toolbox Cognitive Battery will be used to measure fluid cognitive abilities
Assessed at Baseline, 4 weeks, 8 weeks
Trait Mindfulness Levels
Prazo: Assessed at Baseline, 4 weeks, 8 weeks
Using the validated five-facet mindfulness scale (FFMQ) to measure trait mindfulness. FFMQ scores range from 39-195. Higher scores indicate higher trait mindfulness levels.
Assessed at Baseline, 4 weeks, 8 weeks
State Mindfulness Levels
Prazo: Assessed at baseline, 4 weeks, 8 weeks
Using the validated state mindfulness scale (SMS) to measure state mindfulness. SMS scores range from 21-105. Higher scores indicate higher state mindfulness levels.
Assessed at baseline, 4 weeks, 8 weeks

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Overall (in)activity levels
Prazo: Assessed at Baseline, 8 weeks
Using the physical activity and sedentary behavior questionnaire (PASB-Q) to assess older adults' overall (in)activity levels. The questionnaire asks participants about their typical weekly physical activity minutes and daily sitting hours.
Assessed at Baseline, 8 weeks
Overall everyday cognition
Prazo: Assessed at Baseline, 8 weeks
Using everyday cognition scale (ECog) to assess memory, planning, organization, and divided attention in daily contexts. Each item ranges from 1-4 points. The overall score is calculated as an average of all completed items, resulting in a score range of 1 to 4. The higher scores represent worse everyday cognition.
Assessed at Baseline, 8 weeks
Overall health status
Prazo: Assessed at Baseline, 8 weeks
Using SF-36 questionnaire to assess overall health status. For all domain scales and component scores, the scoring range is 0 to 100, with higher scores representing a more favorable or higher level of health.
Assessed at Baseline, 8 weeks
Height
Prazo: Assessed at Baseline, 8 weeks
Applying the NIH PhenX Toolkit protocol. Participants' standing height is measured from the top of the participant's head to their heels. The measure will be conducted in duplicates and will be recorded to the nearest 0.1 cm. This measure will be combined with the weight measure to measure participants' BMI in kg/ m^2.
Assessed at Baseline, 8 weeks
Weight
Prazo: Baseline, 8 weeks
Applying the NIH PhenX Toolkit protocol. Participants' weight will be measured using a digital floor scale. Their weight will be measured in duplicates and will be recorded to the nearest 0.1 kg. This measure will be combined with the height measure to calculate participants' BMI in kg/ m^2.
Baseline, 8 weeks
Mobility
Prazo: Assessed at baseline, 8 weeks
Applying the NIH PhenX Toolkit 10-meter walk protocol to assess mobility. The test outcome is typically expressed as gait speed in meters per second (m/s). The lower values indicate a higher risk of adverse health events.
Assessed at baseline, 8 weeks
Demographics
Prazo: Assessed at baseline
Collected basic demographics via an online survey. All items are assessed using multiple-choice or multiple-selection questions of different types of participants' demographic status. The response options are thus categorical but not a scale.
Assessed at baseline

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

22 de maio de 2026

Conclusão Primária (Estimado)

1 de julho de 2027

Conclusão do estudo (Estimado)

1 de setembro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

16 de maio de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

5 de junho de 2026

Primeira postagem (Real)

10 de junho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

10 de junho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

5 de junho de 2026

Última verificação

1 de junho de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • MODCR00000007

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Ensaios clínicos em Mindfulness-based walking

Se inscrever